# EDGAR Filing Document

**Accession Number:** 0001166834
**File Stem:** 0001213900-25-121682
**Filing Date:** 2025-12
**Character Count:** 12839
**Document Hash:** 3ecdab84cc8e48bf815eab4a4c535698
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-121682.hdr.sgml**: 20251215

**ACCESSION NUMBER**: 0001213900-25-121682

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251215

**DATE AS OF CHANGE**: 20251215

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SHL TELEMEDICINE LTD
- **CENTRAL INDEX KEY:** 0001166834
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94051
- **FILM NUMBER:** 251571688

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 90 YIGAL ALON STREET
- **CITY:** TEL AVIV
- **PROVINCE COUNTRY:** L3
- **BUSINESS PHONE:** 972-3-5612212

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 90 YIGAL ALON STREET
- **CITY:** TEL AVIV
- **PROVINCE COUNTRY:** L3
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Danbar Finance Ltd.
- **CENTRAL INDEX KEY:** 0002005736

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 94 YIGAL ALON ST.
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6789139
- **BUSINESS PHONE:** 972-3-5611152

**MAIL ADDRESS:**
- **STREET 1:** 94 YIGAL ALON ST.
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6789139

## Exhibit 99.1

**Exhibit 1**

**JOINT FILING AGREEMENT**

The undersigned hereby agree that the Schedule 13D with respect to the shares of SHL Telemedicine Ltd. dated as of December 15, 2025, is, and any amendments thereto (including amendments on Schedule 13G) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

---

| | | |
|:---|:---|:---|
| December 15, 2025 |  |  |
|  | DANBAR FINANCE LTD. | DANBAR FINANCE LTD. |
|  | By: | /s/ Nir Rotenberg |
|  | Name: | Nir Rotenberg |
|  | Title: | Director |
|  | MIRI WULKAN | MIRI WULKAN |
|  | /s/ Miri Wulkan | /s/ Miri Wulkan |
|  | NIR ROTENBERG | NIR ROTENBERG |
|  | /s/ Nir Rotenberg | /s/ Nir Rotenberg |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 2)**

**SHL TELEMEDICINE LTD**

*(Name of Issuer)*

**American Depositary Shares, each representing one ordinary share, par value NIS 0.01 per share**

*(Title of Class of Securities)*

**78423T200**

*(CUSIP Number)*

**David Arnon**<br>Chief Executive Officer<br>94 Yigal Alon Street<br>Tel Aviv L3 6789155<br>972-3-5612212

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**12/02/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **78423T200** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Danbar Finance Ltd.** | Name of reporting person<br>**Danbar Finance Ltd.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**L3** | Citizenship or place of organization<br>**L3** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**3165620.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**3165620.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3165620.00** | Aggregate amount beneficially owned by each reporting person<br>**3165620.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**8.5%** | Percent of class represented by amount in Row (11)<br>**8.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

| **CUSIP No.** | **78423T200** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Miri Wulkan** | Name of reporting person<br>**Miri Wulkan** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**L3** | Citizenship or place of organization<br>**L3** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**490528.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**3165620.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**490528.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**3165620.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3656148.00** | Aggregate amount beneficially owned by each reporting person<br>**3656148.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.9%** | Percent of class represented by amount in Row (11)<br>**9.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **78423T200** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Nir Rotenberg** | Name of reporting person<br>**Nir Rotenberg** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**L3** | Citizenship or place of organization<br>**L3** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**175562.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**3165620.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**175562.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**3165620.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3341182.00** | Aggregate amount beneficially owned by each reporting person<br>**3341182.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**9.0%** | Percent of class represented by amount in Row (11)<br>**9.0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
American Depositary Shares, each representing one ordinary share, par value NIS 0.01 per share

**(b) Name of Issuer:**
SHL TELEMEDICINE LTD

**(c) Address of Issuer's Principal Executive Offices:**
94 Yigal Alon Street, Tel Aviv, L3, 6789155

**Item 4. Purpose of Transaction**

This item is not being amended by this Schedule 13D/A.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Reporting Person        Number of Ordinary Shares        Percentage of Class(1)
Danbar Finance Ltd.                  3,165,620                                    8.5%
Miri Wulkan                               3,656,148                                    9.9%
Nir Rotenberg                            3,341,182                                    9.0%

**(b)**
The percentage of class is based on 37,059,946 Ordinary Shares outstanding as of December 3, 2025 (as reported in Exhibit 99.1 to the Issuer's Form 6-K filed with the SEC on December 3, 2025).

Miri Wulkan and Nir Rotenberg are shareholders of Danbar Finance Ltd. ("Danbar"). Ms. Wulkan and Mr. Rotenberg are the sole directors of Danbar. Danbar, Ms. Wulkan and Mr. Rotenberg are collectively referred to herein as the "Reporting Persons".

Danbar is deemed to beneficially own 3,165,620 Ordinary Shares held by it directly.

Ms. Wulkan is deemed to beneficially own 3,656,148 Ordinary Shares, consisting of: (i) 490,528 Ordinary Shares held directly, and (ii) 3,165,620 Ordinary Shares held by Danbar, over which Ms. Wulkan shares voting and dispositive power with Mr. Rotenberg.

Mr. Rotenberg is deemed to beneficially own 3,341,182 Ordinary Shares, consisting of: (i) 175,562 Ordinary Shares held directly, and (ii) 3,165,620 Ordinary Shares held by Danbar, over which Mr. Rotenberg shares voting and dispositive power with Ms. Wulkan.

**(c)**
Reporting Person           Trade Date                      Number of                       Avg. Price Per
                                                                             Ordinary Shares               Ordinary Share(1)
Danbar Finance Ltd.   December 2, 2025                 2,374,215                          CHF 0.60
Miri Wulkan                 December 2, 2025                 367,896                            CHF 0.60
Nir Rotenberg             December 2, 2025                 81,000                               CHF 0.60
Nir Rotenberg             December 4, 2025                 67,562                               CHF 0.78

(1) The price reported is the weighted average price in Swiss franc ("CHF") as of the relevant trade date. The Reporting Persons undertake to provide, upon request by the staff of the SEC, full information regarding the number of Ordinary Shares purchased at each separate price within the ranges set forth in this footnote.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

This item is not being amended by this Schedule 13D/A.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Danbar Finance Ltd.

**Signature:** /s/ Nir Rotenberg

**Name/Title:** Nir Rotenberg/Director

**Date:** 12/15/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Miri Wulkan

**Signature:** /s/ Miri Wulkan

**Name/Title:** Miri Wulkan/Individual

**Date:** 12/15/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Nir Rotenberg

**Signature:** /s/ Nir Rotenberg

**Name/Title:** Nir Rotenberg/Individual

**Date:** 12/15/2025